Erschienen in:
01.11.2008 | Parkinson's Disease and Allied Conditions - Original Article
Mitochondrial DNA haplogroups and subhaplogroups are associated with Parkinson’s disease risk in a Polish PD cohort
verfasst von:
Katarzyna Gaweda-Walerych, Aleksandra Maruszak, Krzysztof Safranow, Monika Bialecka, Gabriela Klodowska-Duda, Krzysztof Czyzewski, Jaroslaw Slawek, Monika Rudzinska, Maria Styczynska, Grzegorz Opala, Marek Drozdzik, Jeffrey A. Canter, Maria Barcikowska, Cezary Zekanowski
Erschienen in:
Journal of Neural Transmission
|
Ausgabe 11/2008
Einloggen, um Zugang zu erhalten
Abstract
mtDNA common variation is inconsistently reported to modify the risk of Parkinson’s disease (PD). We evaluated the impact of the mitochondrial haplogroups, subhaplogroups, coding and non-coding single-nucleotide polymorphisms on PD risk in 241 PD patients and 277 control subjects. After stratification by gender, we found that haplogroup J (OR 0.19; 95% CI 0.069–0.53; P = 0.0014) was associated with a lower PD risk in males. Unexpectedly, subhaplogroup analysis based on the control region (CR) polymorphisms demonstrated that subcluster K1a was more prevalent in healthy controls, while K1c was more frequent in PD patients (P = 0.025 and P = 0.011, respectively; two-tailed Fisher’s exact test). Additionally, we confirmed the hypothesis that sublineages (U4 + U5a1 + K+J1c + J2), previously proposed to partially uncouple oxidative phosphorylation (OXPHOS), decrease PD risk (P = 0.027, χ2 with Yates’ correction). The putative protective effect of uncoupling mtDNAs against PD might result from decreased production of reactive oxygen species. We propose that stratification into subhaplogroups or by gender could be necessary to reveal the involvement of specific mtDNA sublineages in PD pathogenesis.